|
1
|
Zhu W, Cai MY, Tong ZT, Dong SS, Mai SJ,
Liao YJ, Bian XW, Lin MC, Kung HF, Zeng YX, et al: Overexpression
of EIF5A2 promotes colorectal carcinoma cell aggressiveness by
upregulating MTA1 through C-myc to induce
epithelial-mesenchymaltransition. Gut. 61:562–575. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Urosevic J, Garcia-Albeniz X, Planet E,
Real S, Céspedes MV, Guiu M, Fernandez E, Bellmunt A, Gawrzak S,
Pavlovic M, et al: Colon cancer cells colonize the lung from
established liver metastases through p38 MAPK signalling and PTHLH.
Nat Cell Biol. 16:685–694. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
3
|
Chen DL, Wang ZQ, Zeng ZL, Wu WJ, Zhang
DS, Luo HY, Wang F, Qiu MZ, Wang DS, Ren C, et al: Identification
of microRNA-214 as a negative regulator of colorectal cancer liver
metastasis by way of regulation of fibroblast growth factor
receptor 1 expression. Hepatology. 60:598–609. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Yu J, Wu WK, Li X, He J, Li XX, Ng SS, Yu
C, Gao Z, Yang J, Li M, et al: Novel recurrently mutated genes and
a prognostic mutation signature in colorectal cancer. Gut.
64:636–645. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Acunzo J, Katsogiannou M and Rocchi P:
Small heat shock proteins HSP27 (HspB1), αB-crystallin (HspB5) and
HSP22 (HspB8) as regulators of cell death. Int J Biochem Cell Biol.
44:1622–1631. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Zhao GY, Ding JY, Lu CL, Lin ZW and Guo J:
The overexpression of 14-3-3ζ and Hsp27 promotes non-small cell
lung cancer progression. Cancer. 120:652–663. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Shiota M, Bishop JL, Nip KM, Zardan A,
Takeuchi A, Cordonnier T, Beraldi E, Bazov J, Fazli L, Chi K, et
al: Hsp27 regulates epithelial mesenchymal transition, metastasis,
and circulating tumor cells in prostate cancer. Cancer Res.
73:3109–3119. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Huang Q, Ye J, Huang Q, Chen W, Wang L,
Lin W, Lin J and Lin X: Heat shock protein 27 is over-expressed in
tumor tissues and increased in sera of patients with gastric
adenocarcinoma. Clin Chem Lab Med. 48:263–269. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Gibert B, Eckel B, Gonin V, Goldschneider
D, Fombonne J, Deux B, Mehlen P, Arrigo AP, Clézardin P and
Diaz-Latoud C: Targeting heat shock protein 27 (HspB1) interferes
with bone metastasis and tumour formation in vivo. Br J Cancer.
107:63–70. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Liu W, Ma Y, Huang L, Peng J, Zhang P,
Zhang H, Chen J and Qin H: Identification of HSP27 as a potential
tumor marker for colorectal cancer by the two-dimensional
polyacrylamide gel electrophoresis. Mol Biol Rep. 37:3207–3216.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Baylot V, Andrieu C, Katsogiannou M, Taieb
D, Garcia S, Giusiano S, Acunzo J, Iovanna J, Gleave M, Garrido C
and Rocchi P: OGX-427 inhibits tumor progression and enhances
gemcitabine chemotherapy in pancreatic cancer. Cell Death Dis.
2:e2212011. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Lamoureux F, Thomas C, Yin MJ, Fazli L,
Zoubeidi A and Gleave ME: Suppression of heat shock protein 27
using OGX-427 induces endoplasmic reticulum stress and potentiates
heat shock protein 90 inhibitors to delay castrate-resistant
prostate cancer. Eur Urol. 66:145–155. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Andrieu C, Taieb D, Baylot V, Ettinger S,
Soubeyran P, De-Thonel A, Nelson C, Garrido C, So A, Fazli L, et
al: Heat shock protein 27 confers resistance to androgen ablation
and chemotherapy in prostate cancer cells through eIF4E. Oncogene.
29:1883–1896. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Wei L, Liu TT, Wang HH, Hong HM, Yu AL,
Feng HP and Chang WW: Hsp27 participates in the maintenance of
breast cancer stem cells through regulation of
epithelial-mesenchymal transition and nuclear factor-κB. Breast
Cancer Res. 13:R1012011. View
Article : Google Scholar : PubMed/NCBI
|
|
15
|
Wettstein G, Bellaye PS, Kolb M, Hammann
A, Crestani B, Soler P, Marchal-Somme J, Hazoume A, Gauldie J,
Gunther A, et al: Inhibition of HSP27 blocks fibrosis development
and EMT features by promoting Snail degradation. FASEB J.
27:1549–1560. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Mizutani H, Okano T, Minegishi Y, Matsuda
K, Sudoh J, Kitamura K, Noro R, Soeno C, Yoshimura A, Seike M and
Gemma A: HSP27 modulates epithelial to mesenchymal transition of
lung cancer cells in a Smad-independent manner. Oncol Lett.
1:1011–1016. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Cordonnier T, Bishop JL, Shiota M, Nip KM,
Thaper D, Vahid S, Heroux D, Gleave M and Zoubeidi A: Hsp27
regulates EGF/β-catenin mediated epithelial to mesenchymal
transition in prostate cancer. Int J Cancer. 136:E496–E507. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Nasri M, Karimi A and Allahbakhshian
Farsani M: Production, purification and titration of a
lentivirus-based vector for gene delivery purposes. Cytotechnology.
66:1031–1038. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li Y, Xu D, Bao C, Zhang Y, Chen D, Zhao
F, Ding J, Liang L, Wang Q, Liu L, et al: MicroRNA-135b, a HSF1
target, promotes tumor invasion and metastasis by regulating RECK
and EVI5 in hepatocellular carcinoma. Oncotarget. 6:2421–2433.
2015.PubMed/NCBI
|
|
22
|
Acunzo J, Andrieu C, Baylot V, So A and
Rocchi P: Hsp27 as a therapeutic target in cancers. Curr Drug
Targets. 15:423–431. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Arts HJ, Hollema H, Lemstra W, Willemse
PH, De Vries EG, Kampinga HH and Van der Zee AG:
Heat-shock-protein-27 (hsp27) expression in ovarian carcinoma:
Relation in response to chemotherapy and prognosis. Int J Cancer.
84:234–238. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hadchity E, Aloy MT, Paulin C, Armandy E,
Watkin E, Rousson R, Gleave M, Chapet O and Rodriguez-Lafrasse C:
Heat shock protein 27 as a new therapeutic target for radiation
sensitization of head and neck squamous cell carcinoma. Mol Ther.
17:1387–1394. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Guo K, Kang NX, Li Y, Sun L, Gan L, Cui
FJ, Gao MD and Liu KY: Regulation of HSP27 on NF-kappaB pathway
activation may be involved in metastatic hepatocellular carcinoma
cells apoptosis. BMC Cancer. 9:1002009. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Guo K, Liu Y, Zhou H, Dai Z, Zhang J, Sun
R, Chen J, Sun Q, Lu W, Kang X and Chen P: Involvement of protein
kinase C beta-extracellular signal-regulating kinase 1/2/p38
mitogen-activated protein kinase-heat shock protein 27 activation
in hepatocellular carcinoma cell motility and invasion. Cancer Sci.
99:486–496. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Xue L, Yang L, Jin ZA, Gao F, Kang JQ, Xu
GH, Liu B, Li H, Wang XJ, Liu LJ, et al: Increased expression of
HSP27 inhibits invasion and metastasis in human esophageal squamous
cell carcinoma. Tumour Biol. 35:6999–7007. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Pavan S, Musiani D, Torchiaro E, Migliardi
G, Gai M, Di Cunto F, Erriquez J, Olivero M and Di Renzo MF: HSP27
is required for invasion and metastasis triggered by hepatocyte
growth factor. Int J Cancer. 134:1289–1299. 2014. View Article : Google Scholar : PubMed/NCBI
|
